Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Rachna Bedi"'
Autor:
Sara Abou Sherif, Irene Katsaiti, Hannah Jebb, Serena Banh, Rachna Bedi, Jeremy Levy, David Thomas, Damien Ashby, Richard Corbett
Publikováno v:
Clinical Medicine, Vol 24, Iss 4, Pp 100222- (2024)
Inpatient treatment of hyperkalaemia with insulin and dextrose can be complicated by iatrogenic hypoglycaemia. We sought to assess the incidence of hypoglycaemia in hospitalised patients with renal disease and assess the impact of the introduction of
Externí odkaz:
https://doaj.org/article/810359b5cbe0471091ab520d97ece9d7
Autor:
Sarah Gleeson, Paul Martin, Tina Thomson, Katrina J. Spensley, Dawn Goodall, Rachna Bedi, Amarpreet Kaur Thind, Charlotte Seneschall, Jaslyn Gan, Stephen McAdoo, Liz Lightstone, Peter Kelleher, Maria Prendecki, Michelle Willicombe
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
SARS-CoV-2 vaccines are recommended pre-transplantation, however, waning immunity and evolving variants mandate booster doses. Currently there no data to inform the optimal timing of booster doses post-transplant, in patients primed pre-transplant. W
Externí odkaz:
https://doaj.org/article/c103d95d4bed4b4dadf29c874a37276e
Autor:
Andrew H. Frankel, Mona Wahba, Vicky Ashworth, Rachna Bedi, Rachel Berrington, Maria Buckley, Lakshmi Chandrasekharan, Fiona Doyle, Deborah Duval, Frances Game, Susie Hamilton, Sufyan Hussain, June James, Hannah Jebb, Janaka Karalliedde, Marie‐France Kong, Apexa Kuverji, Mark Lambie, Claire Main, Sara Price, Piyumi Wijewickrama, Jennifer Williams, Ketan Dhatariya, Tahseen A. Chowdhury
Publikováno v:
Diabetic medicine : a journal of the British Diabetic AssociationREFERENCES.
Diabetes is the commonest cause of end-stage kidney disease in many parts of the world, and many people on dialysis programmes live with diabetes. Such people are vulnerable to complications from their diabetes, and their care may be fragmented due t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a81d3078c004761b1917efbb6c1dcb02
https://pubmed.ncbi.nlm.nih.gov/36524709
https://pubmed.ncbi.nlm.nih.gov/36524709
Autor:
Katrina J. Spensley, Sarah Gleeson, Paul Martin, Tina Thomson, Candice L. Clarke, Graham Pickard, David Thomas, Stephen P. McAdoo, Paul Randell, Peter Kelleher, Rachna Bedi, Liz Lightstone, Maria Prendecki, Michelle Willicombe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b0f4f5b09f69bc5d14d57f3756f9b88
http://hdl.handle.net/10044/1/96778
http://hdl.handle.net/10044/1/96778
Autor:
Katrina Spensley, Sarah Gleeson, Paul Martin, Tina Thomson, Candice L. Clarke, Graham Pickard, David Thomas, Stephen P. McAdoo, Paul Randell, Peter Kelleher, Rachna Bedi, Liz Lightstone, Maria Prendecki, Michelle Willicombe
BackgroundEmerging data suggest a reduction in SARS-CoV-2 vaccine effectiveness against Omicron SARS-CoV-2 infection. There is also evidence to show that Omicron is less pathogenic than previous variants. For clinically vulnerable populations, a less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f2794fb4de391b3b830aeb025d61814
https://doi.org/10.1101/2022.01.25.22269804
https://doi.org/10.1101/2022.01.25.22269804
Autor:
Paul J. Martin, Kathleen Lynch, Sarah Gleeson, Michelle Willicombe, Liz Lightstone, Rachna Bedi
Publikováno v:
Kidney International
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93bc1fb7826a56513323cbeb96c128e0
https://pubmed.ncbi.nlm.nih.gov/33892859
https://pubmed.ncbi.nlm.nih.gov/33892859
Autor:
Marie Condon, Charles D. Pusey, Pek Ghe Tan, Tom Cairns, Jennifer O'Brien, Megan Griffith, Stephen P. McAdoo, Jeremy Levy, Rachna Bedi
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Truxima is a biosimilar version of rituximab. It was licensed & launched in the United Kingdom in April 2017. A biosimilar medicine is made to be highly similar in quality, safety and efficacy to existing licensed “reference”
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::747555cc7af939dccbacb84d562a2834
https://doi.org/10.1093/ndt/gfaa142.p0374
https://doi.org/10.1093/ndt/gfaa142.p0374
Autor:
S. Gray, Rachna Bedi, Peter H. Winocour, Sara Kazempour-Ardebili, Andrew H. Frankel, Parijat De, June James, Nevine El-Sherbini, Frances L. Game, Tahseen A Chowdhury, Marie-France Kong, Dawn Hardy, G. Ramlan, E. Southcott
Publikováno v:
Diabetic Medicine. 35:1018-1026
Diabetic nephropathy remains the principal cause of end-stage renal failure in the UK and its prevalence is set to increase. People with diabetes and end-stage renal failure on maintenance haemodialysis are highly vulnerable, with complex comorbiditi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba0a4c3d5bcfd9e3459900e2852ec73
https://doi.org/10.1111/dme.13676
https://doi.org/10.1111/dme.13676
Publikováno v:
Rheumatology (Oxford, England). 57(7)
OBJECTIVE B cell depletion, most commonly with rituximab, is an evolving therapeutic approach in SLE. Infusion reactions after rituximab are common, and may prevent re-treatment in patients who previously demonstrated beneficial response. We have use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb00ee5dc6a331913e3932d3c232808
https://pubmed.ncbi.nlm.nih.gov/29562252
https://pubmed.ncbi.nlm.nih.gov/29562252
Autor:
Stephen P, McAdoo, Rachna, Bedi, Ruth, Tarzi, Megan, Griffith, Charles D, Pusey, Thomas D, Cairns
Publikováno v:
Rheumatology (Oxford, England)
Objectives. B cell depletion is an effective treatment strategy in ANCA-associated vasculitis (AAV). Ofatumumab is a fully humanized anti-CD20 mAb that has shown efficacy in the treatment of haematological malignancy and RA. The use of ofatumumab in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b54ecc2f45377088abba8b072010a3c5
https://pubmed.ncbi.nlm.nih.gov/27094598
https://pubmed.ncbi.nlm.nih.gov/27094598